CN102552604A - Medicament for treating prostatitis and prostatic hyperplasia - Google Patents

Medicament for treating prostatitis and prostatic hyperplasia Download PDF

Info

Publication number
CN102552604A
CN102552604A CN2010106207182A CN201010620718A CN102552604A CN 102552604 A CN102552604 A CN 102552604A CN 2010106207182 A CN2010106207182 A CN 2010106207182A CN 201010620718 A CN201010620718 A CN 201010620718A CN 102552604 A CN102552604 A CN 102552604A
Authority
CN
China
Prior art keywords
weight portions
medicament
prostatic hyperplasia
medicine
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010106207182A
Other languages
Chinese (zh)
Inventor
冷刚
袁粉红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010106207182A priority Critical patent/CN102552604A/en
Publication of CN102552604A publication Critical patent/CN102552604A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a medicament for treating prostatitis and prostatic hyperplasia, and belongs to a medicament which is prepared from Chinese medicaments serving as raw materials for treating prostatitis and benign prostatic hyperplasia. The medicament is prepared from rheum officinale, herba lycopi, mirabilite, folium artemisiae argyi, leonurus, fig, plantain herb, wild chrysanthemum, houttuynia cordata, sophora flavescens, angelica root,cassia twig, golden cypress and the like. The medicament has the effects of activating blood and dissolving stasis, clearing heat and removing toxicity, and relieving pains and spasm, can reduce urethral obstruction and improve urinary function, and has low treatment cost, convenient administration, quick response and good treatment effect. Use of 200 clinical cases proves that: the effective rate is 99 percent, and the cure rate is 94.5 percent.

Description

A kind of medicine of treating prostatitis and prostatic hyperplasia
Technical field
The invention provides a kind of medicine of treating prostatitis and prostatic hyperplasia, especially a kind of is the treatment prostatitis processed of raw material and the medicine of prostatic hyperplasia with the Chinese medicine medicine.
Background technology
Prostatitis and prostatic hyperplasia (hypertrophy) are the common diseases of male reproductive system between 50~70 years old.Prostatitis belongs to traditional Chinese medical science stranguria, smart turbid category such as suffer from a deficiency of the kidney, and does not accommodate pain, burning sensation with pudendum, and semen in urine, seminal emission are characteristic.How by the smart chamber of the evil invasion and attack of damp and hot poison, smart road furuncle and phyma, the tonsillitis pyretic toxicity is gone into nutrient blood, or due to the factor such as insobriety, sexual intercourse be unclean.Prostatic hyperplasia belongs to the traditional Chinese medical science " gonorrhea ", " difficulty in urination " category, with trouble urinating, the urine rheology is thin, number of micturitions increases even the completeness urine retention occurs or urinary retention with overflow incontinence is a main symptom.At present, adopting operation, water conservancy diversion, injection or oral drugs to wait clinically usually treats and relief of symptoms.Therapeutic effect is relatively poor, and patient body is painful big, and financial burden is high, also can incur loss through delay optimal treatment period, causes the generation of other diseases.
Summary of the invention
Technical problem to be solved by this invention is a kind of medicine of treating prostatitis and prostatic hyperplasia to be provided, to improve therapeutic effect.
The present invention is achieved in that a kind of medicine of treating prostatitis and prostatic hyperplasia, and it is the medicine of being processed by following raw materials by weight proportions,
Radix Et Rhizoma Rhei 45~55 weight portions
Herba Lycopi's 30~40 weight portions
Natrii Sulfas 45~55 weight portions
Folium Artemisiae Argyi 35~45 weight portions
Herba Leonuri 45~55 weight portions
Fructus Fici 45~55 weight portions
Herba Plantaginis 45~55 weight portions
Flos Chrysanthemi Indici 25~35 weight portions
Herba Houttuyniae 25~35 weight portions
Radix Sophorae Flavescentis 25~35 weight portions
The Radix Angelicae Dahuricae 15~25 weight portions
Ramulus Cinnamomi 25~35 weight portions
Cortex Phellodendri 25~35 weight portions
Squama Manis 45~55 weight portions
Radix Salviae Miltiorrhizae 25~35 weight portions
Radix Paeoniae Rubra 25~35 weight portions
Hedyotidis Diffusae 55~65 weight portions
Semen Arecae 25~35 weight portions.
The medicine of this treatment prostatitis and prostate hyperplasia is that raw material is processed with the Chinese medicine medicine, can play the effect of blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, pain relieving spasmolytic; Can reduce urethral resistance, improve urinary function, medical expense is low; Medication is convenient, instant effect, and therapeutic effect is good; 200 examples are used effective percentage 99%, cure rate 94.5% clinically.
The specific embodiment
Further specify the present invention below.
Hedyotidis Diffusae has another name called Herba Hedyotidis Diffusae, Herba Hedyotidis Diffusae, Herba Commelinae Bengalensis, Chinese Lobelia etc.
The method for preparing of the present invention's medicine is, takes by weighing each crude drug by proportioning, respectively each flavor crude drug pulverized, and crosses 60 mesh sieves, and mix homogeneously, processes powder.Powder by 15~30g one bag, is wrapped into that to process medicated bag in gauze or the non-woven fabrics bag subsequent use.
Take by weighing each material medicine by proportioning again, decoct with boiling machine and process medicinal liquid, and medicinal liquid is concentrated into 1/3~1/2 of original volume, subsequent use in the close device of the glass of packing into.
The method for using of the present invention's medicine is that with the medicinal liquid 8~12ml after concentrating, injection fills in the medicated bag of powder, soaks powder.Two medicated bags after will soaking then stick under patient's umbilicus three respectively and refer to and lumbar vertebra 4, lumbar vertebra are located for 5 liang, take off after 6~8 hours.After sticking, locate with medical proof fabric.Sticked once in per 5 days, 45 days is a course of treatment.Be spaced apart 21 days the course of treatment.The acute bacterial prostatitis patient uses 1 course of treatment, and chronic bacterial prostatitis and prostate hyperplasia, hypertrophy patient use 2 courses of treatment.
It below is clinical observation material.
Use 200 routine patients of the present invention's medicine to be test group.Among the 200 routine patients, minimum 37 years old of age, maximum 87 years old, 52.6 years old mean age.40 examples of the course of disease below 4 years account for 20%; 50 examples in 4~10 years account for 25%; More than 10 years 110 examples, account for 55%.Administrated method is with above-mentioned.
100 routine patients of oral " QIANLIEKANG " board paracetamol are matched group.Oral methods be one time 3~4,3 times on the one.2 months was 1 course of treatment.
In the matched group, situation such as patient's mean age, the course of disease are suitable basically with test group, and comparability is arranged.After two groups of cases are treated two courses of treatment continuously, compare observation.
Curative effect judging standard is:
Clinical cure: observe after 6 months in treatment, pudendum discomfort, pain, burning sensation, semen in urine, seminal emission and transference cures such as frequent micturition, dysuria do not influence sleep and orthobiosis.There is not recurrence in 3 years.
Take a turn for the better: observe after 6 months in treatment, pudendum discomfort, pain, burning sensation, semen in urine, seminal emission and symptoms such as frequent micturition, dysuria obviously alleviate and take a turn for the better.
Invalid: observe after 6 months in treatment, pudendum discomfort, pain, burning sensation, semen in urine, seminal emission and symptoms such as frequent micturition, dysuria, nothing is obviously improved or is increased the weight of.
The Comparison of therapeutic of test group and matched group such as following table:
Figure BSA00000407296100031
Can find out that from the data contrast of test group and matched group the present invention's medication effect significantly is superior to " QIANLIEKANG " board paracetamol commonly used clinically.

Claims (2)

1. a medicine of treating prostatitis and prostatic hyperplasia is characterized in that, it is the medicine of being processed by following raw materials by weight proportions,
Radix Et Rhizoma Rhei 45~55 weight portions
Herba Lycopi's 30~40 weight portions
Natrii Sulfas 45~55 weight portions
Folium Artemisiae Argyi 35~45 weight portions
Herba Leonuri 45~55 weight portions
Fructus Fici 45~55 weight portions
Herba Plantaginis 45~55 weight portions
Flos Chrysanthemi Indici 25~35 weight portions
Herba Houttuyniae 25~35 weight portions
Radix Sophorae Flavescentis 25~35 weight portions
The Radix Angelicae Dahuricae 15~25 weight portions
Ramulus Cinnamomi 25~35 weight portions
Cortex Phellodendri 25~35 weight portions
Squama Manis 45~55 weight portions
Radix Salviae Miltiorrhizae 25~35 weight portions
Radix Paeoniae Rubra 25~35 weight portions
Hedyotidis Diffusae 55~65 weight portions
Semen Arecae 25~35 weight portions.
2. the medicine of prostatitis as claimed in claim 1 and prostatic hyperplasia is characterized in that, described medicine is powder and decoction.
CN2010106207182A 2010-12-25 2010-12-25 Medicament for treating prostatitis and prostatic hyperplasia Pending CN102552604A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010106207182A CN102552604A (en) 2010-12-25 2010-12-25 Medicament for treating prostatitis and prostatic hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010106207182A CN102552604A (en) 2010-12-25 2010-12-25 Medicament for treating prostatitis and prostatic hyperplasia

Publications (1)

Publication Number Publication Date
CN102552604A true CN102552604A (en) 2012-07-11

Family

ID=46400058

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010106207182A Pending CN102552604A (en) 2010-12-25 2010-12-25 Medicament for treating prostatitis and prostatic hyperplasia

Country Status (1)

Country Link
CN (1) CN102552604A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103751336A (en) * 2014-01-12 2014-04-30 韩培海 Traditional Chinese medicine for treating intravenous transfusion extravasation and preparation method thereof
CN103784871A (en) * 2013-12-02 2014-05-14 青岛蓝图文化传播有限公司市南分公司 Chinese medicinal composition for promoting blood circulation to remove meridian obstruction
CN104667027A (en) * 2015-03-31 2015-06-03 华梅 Traditional Chinese medicine liquor for treating prostatic hyperplasia and preparation method of traditional Chinese medicine liquor

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103784871A (en) * 2013-12-02 2014-05-14 青岛蓝图文化传播有限公司市南分公司 Chinese medicinal composition for promoting blood circulation to remove meridian obstruction
CN103751336A (en) * 2014-01-12 2014-04-30 韩培海 Traditional Chinese medicine for treating intravenous transfusion extravasation and preparation method thereof
CN103751336B (en) * 2014-01-12 2015-07-08 韩培海 Traditional Chinese medicine for treating intravenous transfusion extravasation and preparation method thereof
CN104667027A (en) * 2015-03-31 2015-06-03 华梅 Traditional Chinese medicine liquor for treating prostatic hyperplasia and preparation method of traditional Chinese medicine liquor

Similar Documents

Publication Publication Date Title
CN101224291B (en) Plaster for treating breast nodules and preparing method thereof
CN101081261B (en) Medicine for treating hemorrhoids
CN101537107A (en) External use liniment capable of treating dermatomycosis and preparation method thereof
CN103520572A (en) Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition
CN102178814B (en) Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof
CN103301408B (en) Traditional Chinese medicine extract and massage cream prepared from extract
CN103800772A (en) Gynecological external lotion for preventing and treating vagina inflammatory diseases and preparation method thereof
CN102600419B (en) Chinese medicinal composition for treating chronic appendagitis, and preparation method thereof
CN103041262B (en) Traditional Chinese medicine enema for curing chronic prostatitis and preparing method thereof
CN103041247B (en) Traditional Chinese medicine suppository for curing colpitis and preparation method thereof
CN102552604A (en) Medicament for treating prostatitis and prostatic hyperplasia
CN103845617B (en) One treats invisible brightic medicament
CN104888157A (en) Traditional Chinese medicine preparation for treating hysteromyoma and preparation method thereof
CN102379963B (en) Skin wound treating ointment and preparation method thereof
CN102872416B (en) Traditional Chinese medicine sitting lotion for treating chronic prostatitis
CN105012552A (en) Traditional Chinese medicine for treating wind-prevailing migratory arthralgia type rheumatic arthritis and preparation method
CN105456808B (en) Gynaecopathia external prescription
CN1327874C (en) Chinese medicine formulation for treating chronic prostatitis and its preparing method
CN1733197B (en) Medicine for curing chronic prostatitis and process for preparing the same
CN103550708A (en) Chinese herbal compound for treating dysmenorrheal
CN103721191A (en) Traditional Chinese medicinal enema for treating female chronic pelvic inflammation and preparation method thereof
CN102526254B (en) Traditional Chinese medicine composition for treating male prostatitis
CN113230365B (en) Traditional Chinese medicine composition and preparation for treating joint bone diseases as well as preparation method and application of traditional Chinese medicine composition and preparation
CN101810709A (en) Medicament for treating rheumatism
CN102743562B (en) Preparation method of Chinese medicine irrigation solution for treating constipation type trichomonas vaginitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120711